1
Enquiry period
with 07.06.2022 15:42
to 12.06.2022 16:00
2
Bidding period
with 12.06.2022 16:00
to 15.06.2022 16:00
3
Auction
16.06.2022 14:55
4
Evaluation
5
Bids have been evaluated
Status Bids have been evaluated
Estimated value without VAT 34 580 MDL
Period of clarifications: 7 Jun 2022, 15:42 - 12 Jun 2022, 16:00
Submission of proposals: 12 Jun 2022, 16:00 - 15 Jun 2022, 16:00
Auction start date: 16 Jun 2022, 14:55

Supplier technical support:

(+373) 79999801

Glucosum 5% 200ml
Information about customer
Fiscal code/IDNO
Address
2062, MOLDOVA, mun.Chişinău, mun.Chişinău, Burebista, 93
Web site
---
The contact person
Full name
Corina Cebuc
Contact phone
022-55-96-46
Purchase data
Date created
7 Jun 2022, 15:40
Date modified
7 Jun 2022, 15:42
Estimated value (without VAT)
34 580 MDL
The minimum downward of the price
345,80 MDL
Achizitii.md ID
21057815
Type of procedure
Request price offers (goods)
Award criteria
The lowest price
Delivery address
2062, MOLDOVA, mun.Chişinău, mun.Chişinău, Burebista, 93
Contract period
20 Jun 2022 03:00 - 30 Dec 2022 02:00
List of positions
1)
Title
Glucosum 5% 200ml CPV: 33100000-1 - Medical equipments
Quantity: 3082.0
Unit of measurement: Bucata
Documents of the procurement procedure

The offers of the participants are available below, you can view the documents for the offers by clicking on the folder icon.

Based on the Working Group Decision, the selection of a winner requires:

1) Choose winner by clicking the button "Winner.”

2) Отправить в течении 3 дней на почту AAP bap@tender.gov.md отсканированное решение рабочей группы.

4) After choosing the winner, press the button: "Confirm"..

Qualification
Participant(s) name(s)
Normalized price
Status
1
Participant(s) name(s):

DITA ESTFARM S.R.L

Normalized price: 33 311,49 MDL
Status: Winner
Reason: Oderta corespunde cerințelor.
Qualification documents
Documents folder missing
Documents provided with the proposal
The history of the auction
View auction
Unfortunately, questions can be asked only during the "Active" period.
Clarifications